Treatment of vulvar cancer recurrences with electrochemotherapy – a detailed analysis of possible causes for unsuccessful treatment
, , , , , , und
17. Feb. 2023
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 17. Feb. 2023
Seitenbereich: 121 - 126
Eingereicht: 21. Dez. 2022
Akzeptiert: 11. Jan. 2023
DOI: https://doi.org/10.2478/raon-2023-0010
Schlüsselwörter
© 2023 Gregor Vivod, Tanja Jesenko, Gorana Gasljevic, Nina Kovacevic, Masa Bosnjak, Gregor Sersa, Sebastjan Merlo, Maja Cemazar, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1

Figure 2

Figure 3

Review of studies evaluating electrochemotherapy in vulvar cancer
First author, year published | Included no. of patients | Average age | Histology | Response of vulvar cancer |
|
---|---|---|---|---|---|
OR | NR | ||||
Perrone, 201320 | 8 | 84y | 8 SCC | 6/8 (75%) | 2/8 (25%) |
Perrone, 201521 | 25 | 85y | 25 SCC | 20/25 (80%) | 5/20 (20%) |
Pellegrino, 201618 | 10 | 68y | 1 9 Paget’s SCC | 6/10 (60%) | 4/10 (40%) |
Perrone, 201913 | 55 | 79y | 57 SCC 3 Paget’s 1 melanoma | 46/55 (84%) | 9/55 (16%) |
Corrado, 202016 | 15 | 83y | 14 1 SCC CS | 12/15 (80%) | 3/15 (20%) |